# FDA Inspection 1268309 - BioMarin Pharmaceutical, Inc. - March 26, 2025

Source: https://www.globalkeysolutions.net/records/fda_inspections/biomarin-pharmaceutical-inc/4cd4613e-939f-4c47-ab0f-730de2e9c32b/
Source feed: FDA_Inspections

> FDA Inspection 1268309 for BioMarin Pharmaceutical, Inc. on March 26, 2025. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1268309
- Company Name: BioMarin Pharmaceutical, Inc.
- Inspection Date: 2025-03-26
- Classification: No Action Indicated (NAI)
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1268309 - 2025-03-26](https://www.globalkeysolutions.net/api/records/fda_inspections/biomarin-pharmaceutical-inc/82d2a0af-f568-4ba0-b631-24e73e69b55a/)
- [FDA Inspection 1251795 - 2024-08-19](https://www.globalkeysolutions.net/api/records/fda_inspections/biomarin-pharmaceutical-inc/e8b2b049-ebee-414e-99e1-b3ba421792a2/)
- [FDA Inspection 1041169 - 2017-12-14](https://www.globalkeysolutions.net/api/records/fda_inspections/biomarin-pharmaceutical-inc/294a4562-e09d-41ef-b5da-6e26860ddf6d/)
- [FDA Inspection 991276 - 2016-11-04](https://www.globalkeysolutions.net/api/records/fda_inspections/biomarin-pharmaceutical-inc/04c426b2-4a4c-42cc-893a-c7f7b303b7d2/)
- [FDA Inspection 878935 - 2014-04-17](https://www.globalkeysolutions.net/api/records/fda_inspections/biomarin-pharmaceutical-inc/321d151b-0d6a-4a07-8f37-0b8da6e570b6/)

Company: https://www.globalkeysolutions.net/companies/biomarin-pharmaceutical-inc/7811b401-4321-4df1-b9b5-deef8905c101

Office: https://www.globalkeysolutions.net/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d